Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 539 clinical trials
Featured trial
Effects of Almonds on Glycemia in Adults With Elevated Hemoglobin A1c Concentrations

This study will examine the effects of regular almond consumption by individuals with elevated HbA1c on long-term glycemic control.

Accepts healthy volunteers
  • 15 views
  • 15 Jun, 2022
  • 1 location
Featured trial
Aging Research Characterizing Health Equity via Social determinants (ARCHES)

Black Americans have more occurrences of chronic diseases, a higher rate of death, and are at twice the risk of Alzheimer’s disease (AD) compared to White Americans. However, these differences

alzheimer's disease
Accepts healthy volunteers
  • 4 views
  • 23 Jan, 2023
  • 1 location
Featured trial
Pancreatic Insufficiency

Exocrine pancreatic insufficiency (EPI) is a condition that is caused by the inadequate pancreatic enzymes needed for normal digestion and is commonly associated with a wide range of chronic

cancer
disease or disorder
pancreatic enzyme
chronic pancreatitis
pancreatic insufficiency
  • 0 views
  • 27 Jun, 2022
  • 1 location
Featured trial
A clinical trial to evaluate the safety of NLRP3i (inhibitor of a protein called NLRP3) and how it affects the body and brain of people living with early-stage Parkinson’s disease.

This is a Phase 1b study conducted in the US, the UK, and the Netherlands and aiming to better understand the safety of an oral drug in a capsule form which includes a substance called NLRP3 inhibitor. The study aims to understand how the NLRP3 inhibitor affects the body and …

cancer
alpha-synuclein
brain stimulation
levodopa
dementia
  • 1 views
  • 16 Jun, 2022
  • 15 locations
Featured trial
A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis

A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis

  • 248 views
  • 25 Mar, 2021
  • 1 location
Featured trial
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension

A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension

  • 171 views
  • 08 Dec, 2020
  • 1 location
Establishing a Physical Activity Referral Scheme for People With Noncommunicable Diseases in the German Healthcare System (BewegtVersorgt)

The BewegtVersorgt project involved co-producing a physical activity referral scheme (PARS) for inactive persons with underlying non-communicable diseases. Various relevant actors of the German healthcare system (e.g., representatives of physicians, health insurance providers, sports organizations, exercise representatives of exercise professions, representatives of patients) participated in the co-production process. The purpose …

  • 0 views
  • 11 Jul, 2022
  • 1 location
Pneumocystis Pneumonia Diagnosis in HIV- Patients (PNEUMOQUANT)

grafts, transplants, but also from autoimmune or inflammatory chronic diseases. Recent data show that the number of cases occurring in patients Pneumocystis jirovecii pneumonia human

mechanical ventilation
cancer
AIDS
early diagnosis
corticosteroids
  • 3 views
  • 09 May, 2022
  • 3 locations
A Multicenter, Double-blind, Placebo-controlled, Randomized, Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of JNJ-67484703 in Participants With Active Rheumatoid Arthritis

The purpose of this study is to evaluate safety and tolerability of JNJ-67484703 administrations in participants with active rheumatoid arthritis (RA).

methotrexate
antirheumatics
biologic disease-modifying antirheumatic drug
DMARD
body mass index
  • 12 views
  • 10 Oct, 2022
  • 9 locations
Health and Resilience Projects: Foundations (HARP-F)

The Health and Resilience Project (HARP): Foundations is investigating the efficacy of the Strong African American Families (SAAF) intervention in promoting the health and well being of African American adolescents. Youth age 10-13 and their primary caregivers are randomly assigned to receive SAAF or to a control group. Participants complete …

Accepts healthy volunteers
  • 0 views
  • 12 Mar, 2022
  • 1 location